Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 88

Sort by

Sort Order Select

Journal Articles

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Bo Wan, Curtis Hughesman, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Hannah Cherniawsky, Judith Rodrigo, Aly Karsan, Sean Young, Kevin Song, Ryan Stubbins, Cynthia Toze, Jennifer White, Claudie Roy, David Sanford

Blood (2025) 146 (Supplement 1): 1738.

https://doi.org/10.1182/blood-2025-1738

Published: 2025

Journal Articles

Ultra-deep whole-genome sequencing of cell-free DNA recovers most bone marrow-derived mutations in newly diagnosed multiple myeloma

Dor Abelman, David Scott, Jenna Eagles, Stephanie Pedersen, Aimée Wong, Saumil Shah, Cecilia Bonolo De Campos, Darrel White, Irwindeep Sandhu, Kevin Song, Alli Murugesan, Anthony Reiman, Suzanne Trudel, Trevor Pugh

Blood (2025) 146 (Supplement 1): 495.

https://doi.org/10.1182/blood-2025-495

Published: 2025

Journal Articles

Real-world experience with first-line regimens in transplant-ineligible patients with multiple myeloma

Blood (2025) 146 (Supplement 1): 2798.

https://doi.org/10.1182/blood-2025-2798

Published: 2025

Journal Articles

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Eric J. Zhao, Sujaatha Narayanan, Florian Kuchenbauer, Stephen Nantel, Thomas Nevill, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Hannah Cherniawsky, Judith Rodrigo, Kevin Song, Cynthia Toze, Jennifer White, Claudie Roy, Aly Karsan, Ryan Stubbins, David Sanford

Blood (2025) 146 (Supplement 1): 5178.

https://doi.org/10.1182/blood-2025-5178

Published: 2025

Journal Articles

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Blood (2025) 146 (Supplement 1): 2815.

https://doi.org/10.1182/blood-2025-2815

Published: 2025

Journal Articles

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Nicholas Chornenki, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Judith Rodrigo, Claudie Roy, Kevin Song, Cynthia Toze, Jennifer White, David Sanford, Ryan Stubbins

Blood (2025) 146 (Supplement 1): 5222.

https://doi.org/10.1182/blood-2025-5222

Published: 2025

Journal Articles

Real-world outcomes of teclistamab for multiple myeloma in Canada: Multi-institutional report from the Canadian myeloma research group (CMRG) database

Blood (2025) 146 (Supplement 1): 7596.

https://doi.org/10.1182/blood-2025-7596

Published: 2025

Journal Articles

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Blood (2025) 146 (Supplement 1): 6212.

https://doi.org/10.1182/blood-2025-6212

Published: 2025

Journal Articles

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Blood (2025) 146 (Supplement 1): 5806.

https://doi.org/10.1182/blood-2025-5806

Published: 2025

Journal Articles

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Amani Ahmed, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7417.

https://doi.org/10.1182/blood-2024-206077

Published: 2024

Journal Articles

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

Satarupa Mohapatra, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Gagan Kalia, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Deepesh Lad

Blood (2024) 144 (Supplement 1): 7910.

https://doi.org/10.1182/blood-2024-206266

Published: 2024

Journal Articles

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Blood (2024) 144 (Supplement 1): 7649.

https://doi.org/10.1182/blood-2024-193967

Published: 2024

Journal Articles

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Neelan Sriranjan, Shanee Chung, Hannah Cherniawsky, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7113.

https://doi.org/10.1182/blood-2024-211092

Published: 2024

Journal Articles

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Blood (2024) 144 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2024-209687

Published: 2024

Journal Articles

Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)

Donna E Reece, Giovanni Piza Rodriguez, Mariela A Pantoja, Eshetu G Atenafu, Darrell White, Irwindeep Sandhu, Julie Stakiw, Michael Sebag, Terrance Comeau, Kevin Song, Jean Roy, Martha L Louzada, Arleigh McCurdy, Vishal Kukreti, Suzanne Trudel, Anca Prica, Rodger E Tiedemann, Christine I Chen

Blood (2024) 144 (Supplement 1): 3376.

https://doi.org/10.1182/blood-2024-206247

Published: 2024

Journal Articles

Cell-Free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma

Dor D. Abelman, Jenna Eagles, Aimee Wong, Saumil Shah, Stephanie Pedersen, Sarah Bridges, Cecilia Bonolo De Campos, Darrell White, Irwindeep Sandhu, Kevin Song, Zac McDonald, Abir Khaled, Liqiang Yang, Alli Murugesan, Anthony Reiman, Suzanne Trudel, Trevor J. Pugh

Blood (2024) 144 (Supplement 1): 3338.

https://doi.org/10.1182/blood-2024-208740

Published: 2024

Journal Articles

Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Arleigh McCurdy, Engin Gul, Donna Reece, Christopher P. Venner, Darrell White, Jiandong Su, Michael P. Chu, Victor H. Jimenez-Zepeda, Kevin Song, Hira Mian, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Rayan Kaedbey, Martha L Louzada, Richard LeBlanc

Blood (2023) 142 (Supplement 1): 3364.

https://doi.org/10.1182/blood-2023-181138

Published: 2023

Journal Articles

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Shanee Chung, Ashley Kate McEwan, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Sujaatha Narayanan

Blood (2023) 142 (Supplement 1): 6972.

https://doi.org/10.1182/blood-2023-190446

Published: 2023

Journal Articles

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

Shouriyo Ghosh, Florian Kuchenbauer, Ryan J Stubbins, Shanee Chung, Sujaatha Narayanan, Thomas J. Nevill, Kevin Song, Judith Anula Rodrigo, Jennifer White, Claudie Roy, Yasser Abou Mourad, Stephen H. Nantel, Donna L. Forrest, Cynthia L. Toze, Kevin A Hay, Maryse Power, David Sanford

Blood (2023) 142 (Supplement 1): 1482.

https://doi.org/10.1182/blood-2023-182466

Published: 2023

Journal Articles

Genetic Variations in Multiple Myeloma with Extramedullary Disease

Dajung Kim, Seri Jeong, Kevin Song, Jae-Cheol Jo, JiHyun Lee, Jee-Yeong Jeong, Ho Sup Lee

Blood (2023) 142 (Supplement 1): 4742.

https://doi.org/10.1182/blood-2023-181468

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Ultra-deep whole-genome sequencing of cell-free DNA recovers most bone marrow-derived mutations in newly diagnosed multiple myeloma

Real-world experience with first-line regimens in transplant-ineligible patients with multiple myeloma

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Real-world outcomes of teclistamab for multiple myeloma in Canada: Multi-institutional report from the Canadian myeloma research group (CMRG) database

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)

Cell-Free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma

Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

Genetic Variations in Multiple Myeloma with Extramedullary Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only